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Genetic drift of influenza virus genomic sequences occurs through the combined effects of sequence alterations introduced
by a low-fidelity polymerase and the varying selective pressures experienced as the virus migrates through different host
environments. While traditional phylogenetic analysis is useful in tracking the evolutionary heritage of these viruses, the
specific genetic determinants that dictate important phenotypic characteristics are often difficult to discern within the
complex genetic background arising through evolution. Here we describe a novel influenza virus sequence feature variant
type (Flu-SFVT) approach, made available through the public Influenza Research Database resource (www.fludb.org), in
which variant types (VTs) identified in defined influenza virus protein sequence features (SFs) are used for genotype-
phenotype association studies. Since SFs have been defined for all influenza virus proteins based on known structural,
functional, and immune epitope recognition properties, the Flu-SFVT approach allows the rapid identification of the mo-
lecular genetic determinants of important influenza virus characteristics and their connection to underlying biological
functions. We demonstrate the use of the SFVT approach to obtain statistical evidence for effects of NS1 protein sequence
variations in dictating influenza virus host range restriction.
Influenza A virus belongs to theOrthomyxoviridae family (7, 22)and has an enveloped virion that contains a genome made of
eight single-stranded negative-sense RNA segments that code for
either 10 or 11 known proteins, including the surface glycopro-
teins hemagglutinin (HA) and neuraminidase (NA), matrix and
ion-channel proteins (M1 and M2), RNA polymerase subunits
(PB1, PB2, and PA), nucleoprotein (NP), and nonstructural pro-
teins (NS1 and NS2/NEP), with some strains encoding an addi-
tional proapoptotic protein, PB1-F2. Reassortment among the
various influenza virus genome segments occurs frequently (9)
and is particularly observable among the surface glycoproteins.
This phenomenon gives rise to different combinations of serolog-
ically distinct subtypes of HA and NA that circulate in host pop-
ulations. Waterfowl are thought to be the natural reservoirs of
influenza virus; however, the virus is also known to infect several
other hosts, including human, swine, horse, dog, etc., in addition
to a wide variety of avian species (14).
A thorough understanding of any pathogen, including influ-
enza virus, requires an understanding of how variations in the
sequence of the pathogen genome (genotype) are expressed as
differences in the functional characteristics of the pathogen (phe-
notype). It is well known that influenza virus sequences constantly
evolve by accumulating mutations through a process termed “ge-
netic drift,” inwhich sequence variations introduced by the virus’s
low-fidelity polymerase are selected to preserve important struc-
tural and functional protein characteristics while attempting to
evade host immune system recognition.
Comparative genomics studies have largely been restricted to
phylogenetic analysis of whole-genome segments or statistical as-
sociation of sequence variations at single residue positions and
their effects on specific phenotypic characteristics. However, these
traditional approaches to comparative genomics have certain lim-
itations. Single-residue analysis does not take into account the
impact of other genomic residues on the phenotype of interest.
Whole-genome segment analysis does not highlight the specific
regions responsible for the phenotypic effect. In addition, while
the ancestry of genetic variants resulting from the cumulative ef-
fects of evolution can be revealed in the phylogenetic tree topol-
ogy, phenotypic changes arising from convergent evolution are
not revealed through phylogenetic tree reconstruction. Sequence
variations can also influence virus traits that may not be subject to
strong natural selective pressures in the reservoir host, including
host range specificity (1, 15, 16), interspecies transmissibility (1,
4), altered replication (13, 21), virulence and pathogenicity in hu-
man (1, 15), and temperature sensitivity (19). Consequently, tra-
ditional whole-segment phylogenetic analysis may not reveal the
most clinically and epidemiologically relevant sequence altera-
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tions, since the relationships between certain specific phenotypic
changes and their underlying genotypic variationsmay bemasked
by the complex global effects of evolutionary selection on the en-
tire viral genome.
To address these limitations, we have developed a novel
method for studying the effects of sequence variation on organism
phenotypes called the sequence feature variant type (SFVT) ap-
proach, wherein combinations of amino acid positions are de-
fined as discrete sequence features (SFs) based on structural and
functional characteristics. The extent of sequence variation can be
determined for each SF independently as a set of variant types
(VTs) for the SF, which can then be used for statistical analysis of
genotype-phenotype associations. The SFVT approach was first
described for HLA-disease association in the setting of human
autoimmune disease (6). Here we describe the development and
application of the SFVT approach for the study of influenza virus.
MATERIALS AND METHODS
Definition of influenza virus protein sequence features.A sequence fea-
ture (SF) describes a specific region of a protein (or RNA or DNA mole-
cule) possessing some characteristic of interest, for example a known
structural property (e.g., a particular alpha helix or beta strand) (Fig. 1A
and B), functional property (e.g., an enzyme active site, a nuclear local-
ization signal, or a region mediating protein-protein interactions) (Fig.
1C to F), sequence alteration effect (e.g., a position in which a sequence
alteration causes drug resistance), or immune epitope location. For pro-
teins, the formal definition of an SF is the specific string of amino acid
positions thatmakes up the defined region in a particular reference strain.
A given SF can be a contiguous stretch of amino acids in the linear se-
quence (e.g., Fig. 1A) or can be discontinuous (e.g., Fig. 1C), as is often the
case for enzyme active sites or antibody epitopes. There is no limitation on
the size of an SF, as it can range from a single amino acid position with an
interesting characteristic to a complete protein sequence. Individual SFs
can also overlap each other such that a given amino acid position can be
part of several different SFs (e.g., theCPSF30-binding site SF shown in Fig.
1C shares part of the beta-strand SF shown in Fig. 1B).
SFs for influenza virus proteins were defined using information from
the public domain databases UniProt (www.uniprot.org) and the Im-
mune Epitope Database (IEDB, www.iedb.org), and from the published
scientific literature. The initial list of SFs was defined bymining structural
and functional definitions from UniProt records that include manually
FIG1 Examples of selectedNS1 SFs and correspondingVTs. Examples of two different structural and four different functional SFs are shown highlighted in blue
on the 3-dimensional protein structure of the influenza A virus NS1 protein (PDB identifier 2GX9) on the left side of each panel: Influenza virus A_NS1_alpha-
helix_170(19) (A), Influenza virus A_NS1_beta-strand_107(6) (B), Influenza virus A_NS1_CPSF30-binding-site_103(28) (C), Influenza virus A_NS1_nuclear-
export-signal_137(11) (D), Influenza virus A_NS1_NES-mask_148(14) (E), and Influenza virus A_NS1_PKR-binding-site_123(4) (F). The right side of each panel
shows tables of the first 10 VTs for each of these SFs with the amino acid residues that differ from the A/Udorn/1972 reference strain highlighted in red. The
number of influenza virus strains that carry the given VT (strain count) is shown on the left side of the table. The number of amino acid positions that vary in
comparison to the Udorn reference (no. of variations) is shown on the right side; the number of strains that bear the same amino acid sequence VT as the Udorn
reference range from 201 for the CPSF30-binding site SF to 11,703 for the nuclear export signal mask SF.
Noronha et al.
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curated and computationally derived protein features that describe func-
tional motifs, subcellular localization signals, domain structures, second-
ary structural elements, sites of posttranslational modifications, and sites
of virus-virus and virus-host interactions. Experimentally determined
immune epitopes (major histocompatibility complex [MHC] class I and
II-dependent T-cell and B-cell/antibody epitopes) curated through the
efforts of the IEDBwere also included. Publications containing additional
information about protein regions that impact antigenicity, virulence,
pathogenicity, temperature sensitivity, transmission efficacy, host recep-
tor binding, enzyme catalysis, and antiviral drug resistancewere identified
using PubMed searches (www.ncbi.nlm.nih.gov/pubmed). The resulting
publications were then manually curated to identify the amino acid posi-
tion(s) defining the described SF. This initial list of SFs was independently
validated by scientists having expertise in each protein, who reviewed the
SF names and positions for accuracy and added missing SFs to the list.
For each influenza virus protein, a standard reference strain was se-
lected to define the specific amino acid positions that make up each SF.
Reference strains were chosen based on the availability of experimentally
determined crystal structures for the protein and their prominence in
experimental studies (Table 1).
Each SF was annotated with additional relevant information about its
characteristics, including a descriptive name, the influenza virus segment
and protein inwhich it occurs, the amino acid start and stop positions, the
total length, SF category (i.e., structural, functional, sequence alteration,
or immune epitope location), the name of the influenza virus strain in
which it was characterized (which often differed from the reference
strain), any known associated phenotype, evidence codes indicating how
the SF was inferred (e.g., whether it is curated from literature or inferred
from electronic annotations), and the publication or resource wherein it
was initially described.
The SF descriptive name was assigned using the following syntax
wherein every portion of the name is delimited by an underscore:
Influenza virus type_protein symbol_sequence feature type_start position of
the SF (total length of the SF). For example, the Influenza virus
A_H1_cytoplasmic-domain_550(16) SF delineates the cytoplasmic do-
main of the hemagglutinin (HA) protein for subtype H1 of type A influ-
enza virus, which starts at residue 550 and has a total length of 16 amino
acids. In this case, the SF is made of a continuous string of amino acids
between residues 550 and 565. Influenza virus A_H1_sialic-acid-binding-
site_98(17) is an example of a discontinuous SF of theHAprotein (defined
as the set of amino acid positions 98, 134 to 138, 154, 156, 184, 191, 195,
196, and 225 to 229) that is involved in binding to sialic acidmolecules on
host cells. Sequential unique database identifiers were then assigned to
each SF, starting with Influenza virus A_protein symbol_SF1 for each pro-
tein (e.g., Influenza virus A_PB1_SF1).
Determination of influenza virus sequence feature VTs. The extent
of sequence variation for each SF is determined as a collection of variant
types (VTs) computed after multiple sequence alignments of all relevant
influenza virus genomes available in the Influenza Research Database
(IRD). Figure 1 shows the first 10 VTs for each of the SFs displayed. The
first VT (VT-1) corresponds to the specific sequence string found in the
reference strain for that protein. All influenza virus strains in IRD with
amino acid sequences identical to those of the reference strain in that
region are categorized as belonging toVT-1 for that SF. The rest of theVTs
are ordered based on decreasing frequency of representation in the data-
base as of November 2011. For example, in the NS1 nuclear export signal
mask SF, the vast majority of virus strains (11,703) share the same amino
acid sequences with the reference strain (A/Udorn/1972) and thus bear
the VT-1 for this SF (Fig. 1E). In contrast, few strains (201) share the VT-1
reference amino acid sequence for the NS1 CPSF30-binding site SF (Fig.
1C). VT-unknown indicates that the sequence is either not completely
defined or else artificially truncated; hence the SF cannot be defined for
those strains.
The end result is that each set of unique amino acid residue combina-
tions existing within any characterized region of the protein is defined as
an individual sequence feature variant type (SFVT). The SFVT system is
made freely available online to the influenza virus research community
through the NIAID-funded, public Influenza Research Database (IRD,
www.fludb.org) resource (18).
Statistical analyses of the SFVTs of Influenza virus A_NS1_SF18.
Statistical tests were performed using the R package (5) and theMicrosoft
Excel program. For convenience, and to maintain optimal statistical
power, we grouped the virus hosts into seven broad categories: human,
avian (excluding chicken), chicken, swine, equine, environmental sam-
ples, and other host species. We performed two sets of Pearson’s chi-
square tests of independence for the following hypotheses in order to
identify any relationship existing between host groups and the first 16VTs
of Influenza virus A_NS1_SF18: (i) VT distribution across/between host
groups (each host group has an equal probability of containing a partic-
ular VT [16 tests were performed]) and (ii) VT distribution within a host
group (each host group has an equal probability of including all 16 VTs [6
tests were performed]). P values were then calculated for the above hy-
potheses.
Correction for geotemporal data bias.Toperform the corrections for
temporal bias, we assumed that the total number of viruses for all host
groups should be uniform across all years and therefore that the total
number of sequence records derived from data collection should also be
uniform. Each sequence record was assigned an initial temporal weight as
follows: (i) calculate the annual proportion of records (number of records
for each year/total number of records); (ii) calculate the cumulative pro-
portion of records for all years; (iii) remove data for years in which cumu-
lative proportion was 1% to eliminate years that were sparsely repre-
sented, as they would have been assigned an unreasonably high weight;
(iv) randomly choose 90% of the records; (v) calculate the average for the
remaining years; (vi) calculate the temporal weight for the records in a
specific year (temporal weight average/number of occurrences (occur-
rences) in that year); (vii) repeat steps iv to vi 1,000 times; and (viii)
calculate the average temporal weight for each record.
Correction for geographic bias was done in a manner similar to that
for temporal correction by assuming that major global regions of the
world would have roughly the same influenza virus prevalence. Countries
were grouped into 10 broad geographic regions, namely, North America,
South America, Oceania, Europe, North Africa, sub-Saharan Africa,
Northeast Asia, Southeast Asia, Southwest Asia, and unknown (which
included records termed not applicable [N/A] or unknown for country).
To compute the geographic weight, we calculated (i) the average number
of records for each region (excluding unknown) and (ii) the geographic
weight for the records in a specific region: geographic weight average/
number of occurrences (occurrences) in that region. The resultant new
geographic weights for each record were multiplied by the temporal
TABLE 1 SF reference strains for each influenza protein
Segment Protein Serotype Reference strain
GenBank
accession no.
1 PB2 A/Vietnam/1203/2004 EF467805
2 PB1 A/Hong Kong/156/1997 AF036362
2 PB1-F2 A/WSN/1933 CY034138
3 PA A/WSN/1933 CY034137
4 HA H1 A/California/04/2009 FJ966082
H2 A/Japan/305/1957 J02127
H3 A/Aichi/2/1968 AB284320
H5 A/Vietnam/1203/2004 AY818135
H7 A/Turkey/Italy/220158/2002 AY586409
5 NP A/WSN/1933 CY034135
6 NA N1 A/California/07/2009 FJ984386
N2 A/Tokyo/3/1967 U38242
7 M A/Udorn/1972 J02167
8 NS A/Udorn/1972 V01102
Inﬂuenza Virus Protein SFVT
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weights and normalized to get the final geotemporal weights. Normaliza-
tionwas necessary to guarantee that the sumof all weights was the same as
the total number of records. A secondary analysis in which the regional
bias was corrected based on population density using data for total pop-
ulation per region obtained from the Population Reference Bureau re-
source (www.prb.org) was also performed.
RESULTS
As of November 2011, a total of 3,875 SFs have been defined for
the 11 known proteins of type A influenza virus (Table 2). ForHA,
which has 16 known subtypes, SFs are currently defined separately
for the commonly studied subtypes H1, H2, H3, H5, and H7. For
NA, which has 9 known subtypes, SFs are currently defined for N1
andN2. SF definitions will be expanded to the remaining subtypes
in subsequent versions.
The majority of SFs defined thus far belong to the immune
epitope category (Table 2), reflecting the fact that immune
epitopes are easier to define experimentally than other types of
protein functional regions. The number of immune epitope SFs is
roughly proportional to the size of the influenza virus protein,
reflecting the fact that the majority are T-cell epitopes, which,
unlike B-cell/antibody epitopes, are not focused on the surface of
exposed proteins and are reasonably well dispersed along the en-
tire length of proteins. Interestingly, the influenza virus protein
with the largest number of functional SFs is the relatively small
NS1, reflecting the intensity of molecular experimental study fo-
cused on this multifunctional protein (3).
VTs of SFs are identified based on sequence variations that are
observed between influenza virus strains within each SF region in
the entire sequence record available in IRD. The number of VTs
observed is roughly proportional to the length of the SF (Fig. 2).
However, in some cases the number of observed VTs is smaller
than would be expected based on SF size (points below the diag-
onal). These might correspond to regions of the protein that are
under strong evolutionary constraint due to structural or func-
tional requirements. In other cases, the number of VTs is larger
than would be expected (points above the diagonal). These might
correspond to regions under strong positive selective pressure to
change rapidly (e.g., certain immune epitopes).
Once unique VTs have been identified in the sequence record,
influenza virus strains can be annotated and grouped based onVT
membership. Since the VT definition is different for each SF, the
grouping of influenza virus strains based on VT annotations will
be different for each SF. Since influenza virus strain records in IRD
have detailed metadata associated with them, such as country of
isolation, host species, year of isolation, and subtype of the virus,
the different SFVT groupings can be used to investigate genotype
(VT grouping)-phenotype (metadata characteristic) associations.
Host range distribution of NS1 SFVTs. To demonstrate the
utility of the SFVT approach for genotype-phenotype association
analysis, we selected an SF from the influenza virus NS1 protein
Influenza virus A_NS1_SF18 to determine if certain VTs show a
restricted host range. While the influence of surface protein sub-
types (especially HA and NA) on host range constraints has been
well studied, we chose to examine the nonstructural NS1 protein
to determine the extent to which it may contribute to host range
restriction. Influenza virus A_NS1_SF18 is an 11-amino-acid re-
gion involving residues 137 to 147 that is required for nuclear
export of NS1 (8). VT-1 corresponds to the amino acid sequence
found inA/Udorn/1972, which serves as the reference strain for all
NS1 SFs. We examined the isolation host distribution for the first
16 VTs of Influenza virus A_NS1_SF18 since they contained at
least 50 strains within each VT group.
For a given host, the proportion of strains carrying a given VT
was plotted for the first 16 VTs of Influenza virus A_NS1_SF18
(Fig. 3). Four patterns emerged from this analysis. In some cases,
sequences carrying a certain VT were found in restricted host
groups. For example, virtually all equine strains (99%)were found
to carry VT-8 for Influenza virus A_NS1_SF18, and the vast ma-
jority of VT-8-carrying strains (82%) were isolated from horse
(Fig. 3A). Strains carrying VT-4, VT-7, VT-11, VT-12, VT-13, and
VT-14 were predominantly found in avian/chicken hosts and vir-
tually all, except VT-14, were excluded from human (Fig. 3B). In
contrast, strains carrying VT-3, VT-5, VT-9, VT-10, and VT-16
were found predominantly in human and virtually excluded from
avian/chicken (Fig. 3C). Interestingly, swine isolates appeared to
be able to carry either avian-specific (VT-4) or human-specific
(VT-3) VTs. Finally, some VTs (e.g., VT-1, VT-2, VT-6, VT-15)
appeared in isolates from a wide range of hosts (Fig. 3D). The
skewed distribution of many of the Influenza virus A_NS1_SF18
VTs across virus hosts suggested that sequence variations in NS1
might influence host range.
VT evolution. To understand how the Influenza virus
A_NS1_SF18 VTs evolved over time, we inferred their probable
ancestry. We first generated a maximum likelihood-based phylo-
genetic tree using the RAxML (Randomized Axelerated Maxi-
mumLikelihood) program for the region containing the Influenza
virus A_NS1_SF18 and then manually constructed the likely evo-
lutionary history by tracking the accumulation of amino acid sub-
stitutions occurring in the SF over time (Fig. 4).
From the inferred ancestor (VT-0), two major lineages
(branches) emerged, VT-1 and VT-4, and these could be further
separated into sublineages.
The VT-1 lineage began circulating as early as 1902 in diverse
host groups as seen from the sequence records in the IRD re-
source. While viruses carrying VT-1 continue to circulate, VT-1
also gave rise to seven additional sublineages. Three sublineages
TABLE 2 Number of SFs defined for each influenza A virus protein
Protein Subtypea Functional Structural
Immune
epitopes
Sequence
alterations
Total
count
PB2 7 10 514 4 535
PB1-F2 2 2 2 6
PB1 6 5 646 657
PA 1 29 459 1 490
HA H1 4 37 323 364
HA H2 7 7 19 33
HA H3 2 59 362 30 453
HA H5 3 14 40 8 65
HA H7 1 2 3
NP 10 25 421 461
NA N1 10 26 101 4 141
NA N2 9 59 105 6 179
M1 12 14 236 262
M2 7 12 74 1 94
NS1 21 15 93 129
NS2 2 3 62 67
Total 105 321 3,393 56 3,875
a SFs for HA protein are currently defined only for some of the commonly studied subtypes:
H1, H2, H3, H5, and H7. For NA protein, SFs are defined for N1 and N2 subtypes.
Noronha et al.
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were generated due to substitution at NS1 residue 139, including
VT-15 (in 1943, D139G substitution), VT-8 (in 1963, D139E),
and VT-2 (in 1963 with D139N). While the VT-8 sublineage is
predominant in horse and dog, VT-1 and the other 139 variant
sublineages show broad host range distributions. Two sublineages
were generated due to substitution at residue 145—the VT-16 (in
1965, I145T) and VT-9 (in 1979, I145V) sublineages. These sub-
stitutions appear to exclude avian/chicken hosts. In contrast, sub-
lineages with substitutions at residues 137 (VT-14) and 138
(VT-7) appear to prefer avian/chicken hosts, thoughVT-14 is also
seen in human hosts.
VT-4 (I137L, R140Q, I145V, and L146S) appeared as early as
1949 and represents the second major lineage, with VT-11 (2001,
with L141M added to the VT-4 substitutions) and VT-12 (1978,
with D139N added to the VT-4 substitutions) as sublineages. All
VT-4 lineage variants are predominantly restricted to avian/
chicken isolates.
The major VT-1 and VT-4 lineages are consistent with previ-
ous studies defining the A and B alleles of NS1 protein based on
nucleotide sequence homology, with allele B reported to be found
exclusively in avian viruses and allele A found more broadly, in-
cluding human, swine, and avian isolates (10, 20).
This ancestry analysis provides further evidence that sequence
variations in Influenza virus A_NS1_SF18 show skewed distribu-
tion in certain host species, suggesting a possible involvement of
NS1 in restricting the host range phenotype of influenza virus.
Statistical test of skewed host range distribution. Two differ-
ent sets of chi-square tests were performed to determine if the
apparent skewed distributions are statistically significant: (i) tests
of the distribution of each of the 16 VTs of Influenza virus
A_NS1_SF18 across six host groups (Table 3) and (ii) tests of
whether a particular host group has the same probability of con-
taining all VT groups (Table 4). Using a significance cutoff level of
0.05, the first set of tests showed that there are significant and
dramatic differences in the probabilities of host groups carrying a
particular VT. Similarly, the second set of tests showed that there
are also major significant differences in the probabilities of differ-
ent VTs occurring in a specific host group.
A known limitation of the chi-square test is that the absolute
values of the statistic and resultant P values are influenced by the
size of the data set, thereby artificially inflating their maximum/
minimum values. Cramer’s V test is an approach to normalize the
chi-square statistic to control for data set size. Once again, Cram-
er’s V measurement provided further support for the nominal
association between VT and host (see Table S1 in the supplemen-
tal material). These results suggest that the chi-square test is rea-
sonable, that the testing results are significant, and that they pro-
vide support for effects of NS1 genomic features on this key
phenotypic characteristic.
Causes of apparentNS1VT-associatedhost range specificity.
Skewedhost distributions of the sort described above could be attrib-
uted to several factors. Phenotypic differences caused by sequence
FIG 2 Correlation between SF length and number of observed VTs. Scatter plots are used to display the correlations between the length of each SF and the total
number of VTs it contains for all structural SFs (A), all functional SFs (B), and immune epitopes (C) of the H1 subtype of HA protein. A best-fit line is drawn for
each graph. Graphs A and B are generated on a log-log scale to better represent the broad range of data.
Inﬂuenza Virus Protein SFVT
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variations inNS1couldprevent influenzavirus frominfectingand/or
replicating in particular host species. However, the skewed distribu-
tion could also arise due to founder effects resulting in restricted spa-
tial-temporal distribution or due to ascertainment bias from focused
oversampling phenomena. As sequence records in IRD are obtained
from GenBank and from direct submissions, their numbers are
largely influencedby the focusof sequencingefforts. For example, it is
evident thatmore sequencedatahavebeenobtainedduringepidemic
and pandemic outbreaks. The number of sequence records has also
increased exponentially during the most recent decades, particularly
in developed countries withmore in-depth data collection processes
and better surveillance infrastructure. Thus, the recent increase is
likely due to increased data reporting rather than to an absolute in-
crease in the population of influenza viruses circulating worldwide.
To assess the spatial-temporal distributions of the data used, the
number and proportion of strains carrying each VT were further
subdividedby timeandgeographic locationof isolation (Tables5and
6, respectively). VT-13 andVT-14 are predominantly represented by
viruses isolated fromSoutheastAsia (Vietnam)during the years 2003
to 2007, suggesting a probable founder effect. In other cases, skewing
couldbeat leastpartly attributed to samplingbias, including theover-
reporting ofVT-2 sequences in 2009due to oversampling of the pan-
demic H1N1 viruses and the overreporting of VT-1 sequences from
Southeast Asia due to oversampling of avian H5N1 strains. Similar
arguments could alsobemade for theoverrepresentationofVT-11 in
avian hosts since most come from strains obtained through directed
sampling of chickens and environmental samples in New York in
2005 and 2006.
However, these explanations of sampling bias and founder ef-
fects did not hold well for many VT groups that showed restricted
host sources since they also demonstrated broad geographic and
temporal representation. For example, equine VT-8 isolates were
widespread geotemporally but still largely restricted to equine and
canine hosts. Viruses carrying VT-8 had ample opportunities to
infect other hosts as they moved across geographically diverse
countries from 1963 through 2008-2009 and yet did not cross
other host species barriers. Similarly, the avian-predominant
VT-4 lineage and the human-predominant VT-9 and VT-16
groups were also broadly geotemporally diverse, suggesting that
these VTs may indeed be examples of NS1-mediated host range
restrictions.
Effect of debiasing on VT-host statistical associations. In or-
der to better estimate statistical significance by correcting for these
geotemporal data collection biases, we developed a weighting
method based on the underlying assumption that if the sampling
of equal proportions of the influenza virus population had oc-
curred in each year and each location, the total number of records
would have been roughly the same in each year and each geo-
FIG 3 Distribution of host proportions across VTs of Influenza virus A_NS1_SF18. VTs were divided into four groups based on their host representation
patterns. (A) VT-8-carrying viruses were isolated predominantly from equine (and dog; included in the “Others” category). (B) VT-4-, 7-, 11-, 12-, 13-, and
14-carrying viruses were isolated predominantly from chicken and other avian species and environmental samples. (The majority of environmental samples
appear to be derived from avian feces.) (C) VT-3-, 5-, 9-, 10-, and 16-carrying viruses were isolated predominantly from human hosts. (D) VT-1-, 2-, 6-, and
15-carrying viruses were isolated from a broad range of different hosts.
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graphic region. Rather than discarding somedata, we chose to give
each recordwithin the data set a newnormalizedweight to control
for overreporting, as described in Materials and Methods.
The number of SFVT strain records was plotted against their
reported year of isolation for both unprocessed and processed
(weighted) data (see Fig. S1A in the supplemental material). The
rise in the number of unprocessed records around 1997 is most
likely due to the fact that sequencing efforts were extended to all
influenza virus segments, rather than just HA andNA, during that
time. The peaks at 2005-2006 and 2009-2010 correspond to the
avian influenza outbreak and recent swine influenza pandemic,
respectively. The curve for the processed data (dotted line) reflects
how the oversampling bias associated with these episodic events
has been reduced by this temporal weighting strategy. Similarly,
the correction for geographic bias normalized the geographic dis-
tribution of the sequence records (see Fig. S1B).
The chi-square tests described earlier were recalculated using
these processed (weighted) data sets (Table 3). Although the skew-
FIG 4 SFVT lineage tree. The heritage of the first 16 VTs of NS1 Influenza virus A_NS1_SF18 was inferred from the phylogenetic analysis of the amino acid
sequences and the apparent accumulation of amino acid substitutions at the time of first appearance of a particular VT in the sequence record (in parentheses)
from 1902 to 2010. Each VT group is color coded based on the host in which it has circulated. Also shown are the amino acid substitutions (position and amino
acid change) that caused each VT group to be assigned to subsequent “progeny” VTs.
TABLE 3 Chi-square results and P values for unprocessed and
processed datasets
Variant
type dfa
Unprocessed data Processed data
Chi-square
value P value
Chi-square
value P value
VT-1 5 1,978.01 1.00E320 2,307.53 1.00E320
VT-2 5 1,602.69 1.00E320 370.55 6.57E78
VT-3 5 1,631.39 1.00E320 604.83 1.83E128
VT-4 5 1,043.57 2.22E223 1,269.96 2.06E272
VT-5 5 774.93 3.07E165 354.07 2.33E74
VT-6 5 796.81 5.66E170 294.23 1.74E61
VT-7 5 693.02 1.59E147 3,364.64 1.00E320
VT-8 5 8,262.95 1.00E320 9,573.24 1.00E320
VT-9 5 290.96 8.77E61 404.03 4.01E85
VT-10 5 259.70 4.56E54 104.45 6.09E21
VT-11 5 1,490.13 4.05E320 584.51 4.49E124
VT-12 5 75.91 6.02E15 104.86 4.99E21
VT-13 5 98.70 9.95E20 15.52 0.008356874
VT-14 5 101.94 2.06E20 64.53 1.40E12
VT-15 5 70.61 7.66E14 145.27 1.36E29
VT-16 5 48.80 2.44E09 40.15 1.39E07
a df, degrees of freedom.
TABLE 4 Chi-square results and P values for unprocessed and
processed datasets
Host type dfa
Unprocessed data Processed data
Chi-square
value P value
Chi-square
value P value
Avian 15 3,876.49 1.00E320 2,263.90 1.00E320
Chicken 15 1,869.13 1.00E320 3,753.14 1.00E320
Equine 15 8,254.37 1.00E320 9,389.92 1.00E320
Human 15 6,838.78 1.00E320 3,994.25 1.00E320
Othersb 15 1,457.60 6.68E302 587.68 1.47E115
Swine 15 300.45 4.51E55 385.66 7.10E73
a df, degrees of freedom.
b Includes environmental samples and other host species.
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ing was still substantial, data debiasing had a considerable impact
onmany of the P values calculated for these data sets. The P values
for some tests increased dramatically, suggesting that, for these
tests, data collection bias had contributed to the skewed distribu-
tions observed. Correction for temporal bias likely explains the
change in the VT-2 P value, since this is the VT carried by the
pandemic H1N1 2009 viruses, which have been the subject of
massive sequencing scrutiny. Correction for geographic bias likely
explains the change in P value for VT-6, VT-13, and VT-14, since
these viruses were largely restricted to recent Southeast Asian iso-
lates, indicating possible founder effects. VT-3 included records
predominantly from New Zealand and the United States in 2005,
so the calculated chi-square value dropped due to correction for
Oceania. The change in the VT-11 P value was due to correction
for both geographic and temporal bias, as it included samples
mostly from the United States isolated during 2005 and 2006.
Nevertheless all P values were found to be extremely small, both
for the unprocessed data and for the processed data, suggesting
that this region of NS1, alone or in conjunction with other SFs,
appears to have a dramatic impact on host range specificity.
DISCUSSION
We have described an approach wherein the effects of sequence
alterations in influenza virus proteins on virus phenotypic char-
acteristics can be analyzed at a fine level of granularity, by defining
combinations of specific amino acid residues that function as
structural or functional units called sequence features (SFs). Re-
current sequence variations—variant types (VTs)—occurring
within the defined SF region are computed by aligning each SF
from a chosen reference strain to all other related sequences in the
IRD resource (www.fludb.org). The SFVT module is freely avail-
able online to the influenza virus research community through
IRD,which provides access to the complete list of SFs, SFVT align-
TABLE 5 Temporal distribution of sequence records in each VT group
Variant
type
Sequence record count for indicated year of isolationa
1902-1960 1961-1970 1971-1980 1981-1990 1991-1995 1996-2000 2001-2005 2006-2010
VT-1 92 (0.0316) 136 (0.0467) 278 (0.0954) 209 (0.0717) 71 (0.0244) 275 (0.0943) 1,222 (0.4192) 632 (0.2168)
VT-2 0 4 (0.002) 7 (0.0034) 52 (0.0256) 12 (0.0059) 60 (0.0295) 132 (0.0649) 1,768 (0.8688)
VT-3 0 0 0 0 0 334 (0.2387) 705 (0.5039) 360 (0.2573)
VT-4 3 (0.0039) 2 (0.0026) 52 (0.0676) 51 (0.0663) 58 (0.0754) 231 (0.3004) 202 (0.2627) 170 (0.2211)
VT-5 0 0 0 0 0 67 (0.0999) 147 (0.2191) 457 (0.6811)
VT-6 0 0 0 0 3 (0.0048) 169 (0.2713) 416 (0.6677) 35 (0.0562)
VT-7 0 0 0 0 0 0 76 (0.1886) 327 (0.8114)
VT-8 0 4 (0.0245) 25 (0.1534) 44 (0.2699) 26 (0.1595) 3 (0.0184) 16 (0.0982) 45 (0.2761)
VT-9 0 0 8 (0.0279) 42 (0.1463) 174 (0.6063) 57 (0.1986) 3 (0.0105) 3 (0.0105)
VT-10 0 0 0 0 0 0 234 (1) 0
VT-11 0 0 0 0 0 0 143 (0.8882) 18 (0.1118)
VT-12 0 0 1 (0.0192) 0 7 (0.1346) 36 (0.6923) 6 (0.1154) 2 (0.0385)
VT-13 0 0 0 0 0 0 18 (0.2571) 52 (0.7429)
VT-14 0 1 (0.0141) 0 0 1 (0.0141) 1 (0.0141) 62 (0.8732) 6 (0.0845)
VT-15 3 (0.0375) 0 3 (0.0375) 26 (0.325) 2 (0.025) 8 (0.1) 24 (0.3) 14 (0.175)
VT-16 0 1 (0.0154) 2 (0.0308) 1 (0.0154) 10 (0.1538) 33 (0.5077) 18 (0.2769) 0
a The total record count is followed by the proportion of sequences in parentheses.
TABLE 6 Geographic distributions of sequence records in each VT group
Variant
type
Sequence record count for indicated region of isolationa
EUR NAF NAM NEA OCE SAM SEA SSA SWA UNK
VT-1 265 (0.0909) 4 (0.0014) 1,177 (0.4038) 132 (0.0453) 59 (0.0202) 13 (0.0045) 1,222 (0.4192) 12 (0.0041) 26 (0.0089) 5 (0.0017)
VT-2 108 (0.0531) 1 (0.0005) 1,404 (0.6899) 171 (0.084) 68 (0.0334) 49 (0.0241) 222 (0.1091) 0 12 (0.0059) 0
VT-3 63 (0.045) 1 (0.0007) 655 (0.4682) 39 (0.0279) 485 (0.3467) 35 (0.025) 104 (0.0743) 0 17 (0.0122) 0
VT-4 86 (0.1118) 0 520 (0.6762) 47 (0.0611) 8 (0.0104) 21 (0.0273) 75 (0.0975) 6 (0.0078) 6 (0.0078) 0
VT-5 20 (0.0298) 0 386 (0.5753) 46 (0.0686) 157 (0.234) 30 (0.0447) 31 (0.0462) 0 1 (0.0015) 0
VT-6 0 0 3 (0.0048) 6 (0.0096) 0 0 614 (0.9856) 0 0 0
VT-7 79 (0.196) 20 (0.0496) 0 64 (0.1588) 0 12 (0.0298) 43 (0.1067) 122 (0.3027) 63 (0.1563) 0
VT-8 6 (0.0209) 0 236 (0.8223) 10 (0.0348) 0 0 33 (0.115) 0 2 (0.007) 0
VT-9 48 (0.2945) 1 (0.0061) 74 (0.454) 7 (0.0429) 2 (0.0123) 9 (0.0552) 18 (0.1104) 2 (0.0123) 1 (0.0061) 1 (0.0061)
VT-10 32 (0.136) 0 82 (0.3504) 0 117 (0.5) 0 3 (0.0128) 0 0 0
VT-11 0 0 161 (1) 0 0 0 0 0 0 0
VT-12 33 (0.6346) 0 16 (0.3077) 0 0 3 (0.0577) 0 0 0 0
VT-13 1 (0.0141) 0 3 (0.0423) 0 0 0 67 (0.9437) 0 0 0
VT-14 0 0 0 0 0 0 70 (1) 0 0 0
VT-15 8 (0.1) 1 (0.0125) 45 (0.5625) 3 (0.0375) 0 0 22 (0.275) 1 (0.0125) 0 0
VT-16 4 (0.0615) 0 26 (0.4) 1 (0.0154) 17 (0.2615) 0 17 (0.2615) 0 0 0
a Abbreviations: EUR, Europe; NAF, North Africa; NAM, North America; NEA, Northeast Asia; OCE, Oceania; SAM, South America; SEA, Southeast Asia; SSA, sub-Saharan Africa;
SWA, Southwest Asia; UNK, unknown. The total count is followed by the proportion of sequence records in parentheses.
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ments, and metadata associated with the VT sequences, including
host, country and year of isolation, and virus subtype.
By compiling the set of all currently characterized SFs for in-
fluenza virus proteins, a valuable resource that can be used as a
reference for all characterized influenza virus protein regions has
been created. Each defined SF is associated with links to relevant
publications, protein annotations, and protein structure records
through PubMed, UniProt, PDB, and IEDB. The SFVT system is
designed to support the addition of new SFs as they become avail-
able without altering the existing list. In an effort to make the
SFVT component as comprehensive and up-to-date as possible,
we are now creating a community-based annotationweb interface
to allow external researchers and IRD curators to submit new SFs
to the system. The user interface for data capture will contain
some required fields (e.g., virus name, SF positions, category and
definition, submitter’s name and affiliation, etc.) that the submit-
ter will need to provide, while other fields will be populated auto-
matically by the IRD system (e.g., SF identity [ID] and length)
based on the primary data entered into the required fields. SFs
submitted using this method will be internally validated for com-
pleteness, accuracy, and nonredundancy and subsequently re-
viewed by influenza virus experts before public release. In addi-
tion, IRD will automatically add new SFs from the UniProt and
IEDB resources using custom parsing scripts.
In an effort to demonstrate the utility of this approach in study-
ing genetic determinants of virus phenotypes, we performed com-
putational and statistical analysis on the VTs of the Influenza virus
A_NS1_SF18 of the NS1 protein for their potential correlation
with host range restriction. Even after controlling for data collec-
tion biases, highly significant P values and dramatically skewed
distributions of VTs were observed across different host groups,
suggesting that sequence variations in Influenza virus A_NS1_
SF18 appear to impact host range restriction with high statistical
confidence.
For a virus to spread, it should have both the opportunity and
capability to infect a given host. A virus infection within an iso-
lated community, for example, might result in all individuals car-
rying a particular substitution carried by the founder virus; how-
ever, those living outside of that specific community may lack the
substitution because of a lack of opportunity for the founder virus
or its progeny to infect them. We checked to see if this kind of
founder effect could explain the associations observed in our data
set but found just the opposite to be true in many cases. For ex-
ample, viruses carryingVT-8, whichwere found to infect predom-
inantly horses and dogs, had ample opportunity to spread based
on their worldwide occurrence over more than 45 years, and yet
they continued to remain within their preferred host species. In
fact, the only evidence of cross-species virus spreading from
horses to another host group was at a racetrack inMiami, Florida,
where dogs and horses raced at the same facility (2). Although
most viruses in the VT-8 group also belong to the H3N8 subtype,
it is clear from the sequence records that H3N8 viruses circulate
effectively in birds and other hosts. Thus, the restriction of certain
influenza viruses to equine and canine species appears to be dic-
tated, at least in part, by sequence variations in the NS1 protein.
Similar arguments can be made for the associations between the
VT-4 lineage and avian host restriction and the VT-9 and VT-16
lineages and human host restriction.
It should be noted that for statistical inference, the data set used
here cannot be considered as a random sample from the entire
population of influenza virus-infected hosts, since the data re-
cords are from diverse sources and are based on free response data
collection schemes and therefore may not be independent or ran-
dom. One consequence of this observation is that the P values
from chi-square analysis may be biased. Despite the fact that we
cannot prove the independence and randomness of the data, we
know that the records are at least from different regions of the
world and were collected at different time points throughout sev-
eral decades. Indeed,while our approach to control for geographic
and temporal biases resulted in changes in the chi-square statisti-
cal values, the extreme skewing inVT-host distributions remained
significant.
The geographic bias in the data could be attributed at least
partially to difference in population density of host species. To
control for this contribution to geographic bias, we repeated the
chi-square analysis by also adjusting for virus prevalence per cap-
ita in humanpopulations across different regions of theworld (see
Table S1 in the supplemental material). Once again, while the
absolute values of the chi-square statistics and P value changed,
the extreme skewing in VT-host distributions remained signifi-
cant. However, it should be noted that this adjusts only for the
effects of population density of the human host; population den-
sity information for the other influenza virus host species is not
readily available in order to perform a similar adjustment of their
effects.
As an alternative to the chi-square analysis, we also applied an
association rule data-mining method to investigate the relation-
ship between VTs and host groups. One advantage of this method
is that it does not require independent data or randomsampling to
infer results. For this data-mining process, we separately consid-
ered two rules, namely, VT-to-host-type and host-type-to-VT re-
lationships, and therefore for each direction we had 96 (16 · 6 
96) possible rules. These rules were then assessed using two com-
mon evaluation criteria—support and confidence. Using 0.5 as a
confidence cutoff, we ended up with two significant rules from
host type to variant type (avian to VT-1 and equine to VT-8) and
11 significant rules from variant type to host type (VT-1, VT-4,
VT-12, VT-13, and VT-14 to avian; VT-8 to equine; and VT-2,
VT-3,VT-5,VT-10, andVT-16 to human), providing further sup-
port for the role of NS1 sequence variations in host range restric-
tion (see Table S2 in the supplemental material).
To determine if sequence variations in Influenza virus
A_NS1_SF18 are independent predictors of virus host range, we
performed additional analysis of variance (ANOVA) tests to ex-
amine themain effects of host type, VT, HA subtype, NA subtype,
and the two-way interactions of host type by VT, host type byHA,
host type by NA, VT by HA, and VT by NA using the number of
records as the response variable (see Table S3 in the supplemental
material). In the ANOVA output, we see that the overall model is
significant with P value F statistics of0.0001, indicating that the
model is valid. Since the interaction of host type and NA is signif-
icant (P value of 0.0037), we know that at least one pair of response
variables for different combinations of host type and NA is differ-
ent from each other. Hence, there is no need to look at their main
effects because the possible significance of their main effects could
be driven by their interactions. This finding agrees with the prior
knowledge that certain host types are associated with certain virus
NA subtypes. We also find that the P value for the interaction of
VT and host is less than 0.0001, thus verifying our conclusion that
VT is highly associated with host type. However, neither the inter-
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action of VT and HA nor that of VT and NA is significant, imply-
ing that there is insufficient evidence of an association betweenVT
and either NA or HA subtype. Therefore, virus subtype is not a
confounding variable in ourNS1VT analysis, even though theNA
subtype is also associated with host type. Thus, the association
between host type and VT is verified and therefore NS1 sequence
variation can be considered as an independent factor dictating
host range restriction.
Several previous studies have provided evidence of a role for
NS1 sequence variation in differential replication and pathogenic-
ity in different host species, but most of the studies were focused
on awhole-segment analysis strategy. Reassortant viruses carrying
aberrant NS segments from the cold-adapted CR43 clone 3 virus
were defective for replication inMadin-Darby canine kidney cells
and ferrets (12). Reassortant A/Udorn/72 viruses carrying the B
allele of NS1 from avian viruses were found to be attenuated for
replication in the respiratory tract of squirrelmonkeys in compar-
isonwith the same virus carrying the A allele of NS1 (20). TheNS1
protein from the A/Goose/Guangdong/1/96 (H5N1) strain in-
creased the replication efficiency of the A/FPV/Rostock/34
(H7N1) strain in human and mouse cell lines (11). These studies
and others provide clear evidence of a role for NS1 in host range
restriction at the segment level. More recently, the C-terminal
ESEV/RSKVmotif, conserved in avian andhuman viruses, respec-
tively, was shown to affect replication in a species-specificmanner
in cell culture and animals (17). While all the statistical tests per-
formed in this study provide strong evidence for the role of Influ-
enza virus A_NS1_SF18 in contributing to host specificity, we can-
not definitively conclude that the cellular nuclear export
machinery is solely responsible for host restriction, as we have not
yet completed an in-depth analysis of all other NS1 SFs for corre-
lation with this phenotype. However, the SFVT strategy should
allow us to rapidly identify the most likely candidates. Ultimately,
experimental validations will be required to elucidate the connec-
tions betweenVT-mediated host range specificity and the relevant
cellular/biochemical processes.
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